Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.

The advent of anti-TNF biological agents has been a massive advance in our treatment of RA and other inflammatory diseases. However, it is acknowledged that there are major drawbacks, the greatest being cost. There is, therefore, clearly a massive market for small molecular weight inhibitors that wo...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Foxwell, B, Andreakos, E, Brennan, F, Feldmann, M, Smith, C, Conron, M
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: 2003

অনুরূপ উপাদানগুলি